Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostaglandin d2 as a potential antithrombotic agent

E E Nishizawa, W L Miller, R R Gorman

    Prostaglandins
    |January 1, 1975
    PubMed
    Summary

    Prostaglandin D2 (PGD2) effectively inhibits platelet aggregation, showing stronger effects than PGE1 in humans. PGD2 also offers a longer-lasting antithrombotic effect with fewer cardiovascular side effects, suggesting its potential therapeutic use.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Nocturnal glycemic variability and sleep architecture in children and adolescents with type 1 diabetes: A multi-night home sleep study.

    Sleep medicine·2026
    Same author

    Arabidopsis GH3.10 conjugates jasmonates.

    Plant biology (Stuttgart, Germany)·2025
    Same author

    Inner southern magnetosphere observation of Mercury via SERENA ion sensors in BepiColombo mission.

    Nature communications·2022
    Same author

    Age-period-cohort modelling of type 1 diabetes incidence rates among children included in the EURODIAB 25-year follow-up study.

    Acta diabetologica·2022
    Same author

    Phase-contrast enhanced synchrotron micro-tomography of human meniscus tissue.

    Osteoarthritis and cartilage·2022
    Same author

    Pre-hospital emergency nurse specialist's experiences in caring for patients with non-specific chief complaints in the ambulance - A qualitative interview study.

    International emergency nursing·2022

    Area of Science:

    • Biochemistry
    • Pharmacology
    • Cardiovascular Research

    Background:

    • Platelet aggregation is crucial in thrombosis.
    • Prostaglandins like PGD2 and PGE1 are known to modulate platelet function.
    • Understanding the comparative effects of different prostaglandins is vital for developing antithrombotic therapies.

    Purpose of the Study:

    • To compare the inhibitory effects of Prostaglandin D2 (PGD2) and Prostaglandin E1 (PGE1) on platelet aggregation.
    • To evaluate the duration of PGD2's inhibitory effect on platelet aggregation.
    • To assess the cardiovascular effects of PGD2 compared to PGE1.

    Main Methods:

    • In vitro platelet aggregation assays using human and rabbit platelets stimulated by ADP, collagen, and prostaglandin G2.
    • In vivo studies assessing the duration of PGD2's effect after intravenous and oral administration.

    Related Experiment Videos

  • Measurement of hypotensive effects on the cardiovascular system.

    • Main Results:

    • PGD2 demonstrated a more potent inhibition of human platelet aggregation compared to PGE1.
    • While PGE1 was more potent in inhibiting ADP-induced aggregation in rabbit platelets, PGD2 exhibited a longer-lasting inhibitory effect.
    • PGD2 showed less significant hypotensive effects on the cardiovascular system than PGE1.

    Conclusions:

    • PGD2 is a potent inhibitor of platelet aggregation with a prolonged duration of action.
    • PGD2's favorable cardiovascular profile suggests its potential as a safer antithrombotic agent compared to PGE1.
    • Further research into PGD2 as an antithrombotic therapy is warranted.